Aziyo Biologics Announces Voluntary Recall Of Viable Bone Matrix Products Treated With A Product From A Single Donor Lot
Portfolio Pulse from Benzinga Newsdesk
Aziyo Biologics has announced a voluntary recall of its viable bone matrix products that were treated with a product from a single donor lot. The company has not provided any details on the reason for the recall or its potential impact.
July 13, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aziyo Biologics has recalled its viable bone matrix products. The reason for the recall and its potential impact have not been disclosed.
Product recalls often have a negative impact on a company's stock price in the short term, as they can lead to lost sales and damage to the company's reputation. However, the specific impact on Aziyo Biologics' stock price will depend on the reason for the recall and its potential consequences, which have not been disclosed.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100